Agilux Laboratories, Inc.

Agilux Laboratories, Inc.

Agilux Laboratories, Inc.

Overview
Date Founded

2007

Headquarters

3 Biotech Park,1 Innovation Drive,Worcester, MA 01605

Type of Company

Private

Industries

Medical Support Services
Insurance Brokerage

Company Description

Agilux Laboratories, Inc. provides bioanalytical, pharmacokinetic, and pharmacodynamic services. It offers discovery bioanalysis, Vivo pharmacokinetic services, vitro ADMET, biomarker assays and GLP bioanalysis services . The company was founded by Jim Jersey, Steve Guyan, and Peter H. Glick in 2007 and is headquartered in Worcester, MA.

Contact Data
Trying to get in touch with decision makers at Agilux Laboratories, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Co-Founder

Co-Founder

Head of GLP Bioanalysis, Bioanalytical Operations

Senior Director-Operations & IT

Senior Director, Finance & Administration

Senior Director-Pharmacology

Senior Director, Business Development

Director, Discovery Bioanalysis

Director, Discovery Bioanalysis

Board of Directors

Co-Founder at Agilux Laboratories, Inc.

Managing Partner at Ampersand Management LLC

General Partner at Ampersand Management LLC

Paths to Agilux Laboratories, Inc.
Potential Connections via
Relationship Science
You
Agilux Laboratories, Inc.
Recent Transactions
Details Hidden

Charles River Laboratories International, Inc. purchases Agilux Laboratories, Inc. from Ampersand Management LLC

Investors
Details Hidden

Ampersand Management LLC invests in middle market companies located in North America and Europe. The firm focuses on companies with revenues between $10 and $100 million. They targets companies operating in the fields of healthcare technology, healthcare services, pharma services and laboratory services. They provides financing for growth, MBO, corporate divestitures and recapitalization capital requirements with an investment size ranging between $10 and $50 million. They acquires both majority and minority interests.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Agilux Laboratories, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Agilux Laboratories, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Agilux Laboratories, Inc..